BETA ADRENERGIC RECEPTOR BLOCKER FOR

Brand Owner Address Description
APTIN ASTRA PHARMACEUTICAL PRODUCTS, INC. 444 MADISON AVENUE MANHATTAN NY BETA-ADRENERGIC RECEPTOR BLOCKER FOR THE MANAGEMENT AND TREATMENT OF CARDIAC ARRHYTHMIAS, ANGINA PECTORIS, AND OTHER CARDIOVASCULAR DISEASES;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods of using a genetic polymorphic variation in the human beta-1 adrenergic receptor gene as a drug response marker are presented. Determining the presence or absence of the A145G genetic variation in the human beta-1 adrenergic receptor gene is useful in predicting an individual's relative response to different antihypertensive drugs; optimizing antihypertensive treatment for an individual; selecting candidate human subjects for participation in clinical trials involving antihypertensive drugs; and, predicting the relative responses among a plurality of individuals to an antihypertensive drug.